IRADIMED CORPORATION Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
IRADIMED CORPORATION (IRMD) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $216.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-07-31
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $216.00K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $279.00K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $111.24K.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $225.65K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $216.00K 10-Q · filed 2026-07-31 |
| 2026-03-31 | $279.00K 10-Q · filed 2026-05-01 |
| 2025-09-30 | $111.24K 10-Q · filed 2025-11-03 |
| 2025-06-30 | $225.65K 10-Q · filed 2025-08-01 |
| 2025-03-31 | $178.18K 10-Q · filed 2025-05-05 |
| 2024-09-30 | $59.52K 10-Q · filed 2024-10-31 |
| 2024-06-30 | $114.46K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $171.90K 10-Q · filed 2024-05-02 |
| 2023-09-30 | $25.24K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $50.47K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $75.71K 10-Q · filed 2023-05-04 |
| 2022-09-30 | $25.24K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $50.47K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $75.05K 10-Q · filed 2022-05-06 |
| 2021-09-30 | $25.26K 10-Q · filed 2021-11-05 |
| 2021-06-30 | $50.51K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $75.31K 10-Q · filed 2021-05-07 |
| 2020-09-30 | $23.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $46.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $67.47K 10-Q · filed 2020-05-07 |
| 2019-09-30 | $22.49K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $44.98K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $67.47K 10-Q · filed 2019-05-08 |
| 2018-09-30 | $22.49K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $44.98K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $67.47K 10-Q · filed 2018-05-08 |
| 2017-09-30 | $20.60K 10-Q · filed 2017-11-06 |
| 2017-06-30 | $41.20K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $61.80K 10-Q · filed 2017-05-05 |
| 2016-09-30 | $2.63K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $5.27K 10-Q · filed 2016-08-05 |
| 2016-03-31 | $10.67K 10-Q · filed 2016-05-06 |
| 2015-09-30 | $8.83K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $17.66K 10-Q · filed 2015-08-11 |
| 2015-03-31 | $26.49K 10-Q · filed 2015-05-11 |
| 2014-09-30 | $9.86K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $19.72K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |